The Milken Institute's Center for Strategic Philanthropy and its predecessor, the Philanthropy Advisory Service, have conducted more than a dozen deep dives into "disease philanthropy." These inquiries have yielded valuable lessons on how philanthropists and family offices can make a difference in a wide range of diseases such as Parkinson's Disease, End Stage Renal Disease, Melanoma and many more. This panel will examine the following questions:

• How can medical philanthropy evolve beyond "checkbook" philanthropy?
• What experiences are the most gratifying and challenging for the philanthropist?
• Compared to government resources for scientific research, will medical philanthropic capital always be marginal? Can it be transformative when it targets a specific disease?